75 Recruiting Solid Tumors Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Solid Tumors
Related Conditions
Top Recruiting Solid Tumors Studies
Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
View Study & Checklist ➔Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours
📍 Research Site — Edmonton, Alberta
View Study & Checklist ➔Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
📍 University of California - Los Angeles - 300208353 — Santa Monica, California
View Study & Checklist ➔A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial
📍 Santa Casa de Misericordia de Porto Alegre — Porto Alegre, Rio Grande do Sul
View Study & Checklist ➔Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors
📍 Angeles Clinic and Research Institute — Los Angeles, California
View Study & Checklist ➔Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
📍 Phoenix Children's Hospital — Phoenix, Arizona
View Study & Checklist ➔A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors
📍 The Angeles Clinic and Research Institute — Los Angeles, California
View Study & Checklist ➔A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours
📍 University of Arizona Cancer Center, 3838 N. Campbell Avenue, RM 2111, Site 203 — Tucson, Arizona
View Study & Checklist ➔Study of INCB123667 in Subjects With Advanced Solid Tumors
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Dexamethasone for Symptom Burden in Advanced Cancer Patients
📍 Lyndon Baines Johnson Hospital — Houston, Texas
View Study & Checklist ➔A Study in People With Advanced Cancer to Test How Well Different Doses of BI 770371 Alone or in Combination With Ezabenlimab Are Tolerated
📍 Florida Cancer Specialists-Sarasota-61670 — Sarasota, Florida
View Study & Checklist ➔Avelumab Program Rollover Study
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔GEN1046 Safety Trial in Patients With Malignant Solid Tumors
📍 Mayo Clinic — Phoenix, Arizona
View Study & Checklist ➔Research Study Utilizing Expanded Multi-antigen Specific Lymphocytes for the Treatment of Solid Tumors
📍 Children's National Medical Center — Washington D.C., District of Columbia
View Study & Checklist ➔Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
📍 Western Regional Medical Center at Cancer Treatment Centers of America — Goodyear, Arizona
View Study & Checklist ➔A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
📍 UCLA Healthcare Hematology-Oncology — Santa Monica, California
View Study & Checklist ➔A Study of ADRX-0706 in Select Advanced Solid Tumors
📍 USC Norris Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers
📍 Yale University — New Haven, Connecticut
View Study & Checklist ➔Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors
📍 Smilow Cancer Hospital Phase 1 Unit — New Haven, Connecticut
View Study & Checklist ➔Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
📍 Rigshospitalet — København Ø,
View Study & Checklist ➔Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
📍 University of California San Diego — La Jolla, California
View Study & Checklist ➔Phase II Biomarker Study of BND-22 in Combination With Cemiplimab in Solid Tumors
📍 Md Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Study of AUBE00 in Patients With Solid Tumors
📍 South Texas Accelerated Research Therapeutics (START) Midwest — Grand Rapids, Michigan
View Study & Checklist ➔JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
📍 Henry Ford Health System — Detroit, Michigan
View Study & Checklist ➔DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
📍 USA06-0 — Los Angeles, California
View Study & Checklist ➔APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
📍 Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute — Los Angeles, California
View Study & Checklist ➔A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
📍 GSK Investigational Site — Birmingham, Alabama
View Study & Checklist ➔A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
📍 The Angeles Clinic and Research Institute — Los Angeles, California
View Study & Checklist ➔PumaRx Registry Trial
📍 Baptist Health South Florida — Coral Gables, Florida
View Study & Checklist ➔A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
📍 New York Medical College — Valhalla, New York
View Study & Checklist ➔A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
📍 Investigative Site US058 — Birmingham, Alabama
View Study & Checklist ➔The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
📍 St. Joseph's Hospital and Medical Center — Phoenix, Arizona
View Study & Checklist ➔JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
📍 Research Site — Denver, Colorado
View Study & Checklist ➔DPTX3186 in Wnt Pathway Activated Solid Tumors
📍 NEXT San Antonio — San Antonio, Texas
View Study & Checklist ➔A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔QTX3034 in Patients With KRAS G12D Mutation
📍 UCLA Hematology/Oncology — Los Angeles, California
View Study & Checklist ➔A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)
📍 Valkyrie Clinical Trials — Los Angeles, California
View Study & Checklist ➔ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors
📍 UH Cleveland Medical Center — Cleveland, Ohio
View Study & Checklist ➔